Noninvasive fetal RHD testing is emerging as a standard of care: insights from a global survey
Alloimmunization against Rhesus D (RhD) is the leading cause of hemolytic disease of the fetus and...
Devyser Index Plate LB-192 (8-R207) is intended for use as an accessory only in conjunction with the following products:
• Devyser Chimerism (8‑A107)
• One Lambda™ Devyser Chimerism (8-R107)
• One Lambda™ Devyser Accept cfDNA (8-R114)
• Devyser CFTR (8-R101)
• Devyser Thalassemia v2 (8-R117)
Instructions for use
Enter access code found in the lower right corner of the label on the kit box.
Certificates
Download a specific Batch Release Certificate (BRC) below.
Guidelines and handbooks (0)
Product information (0)
Software settings (0)
Safety data sheets (0)
Data tables (0)
Enter access code found in the lower right corner of the label on the kit box.
Download a specific Batch Release Certificate (BRC) below.
Contact us to discover how we can help streamline your lab workflow.
Alloimmunization against Rhesus D (RhD) is the leading cause of hemolytic disease of the fetus and...
Read More
For many laboratories, CFTR testing is not an occasional add-on. It is part of a routine,...
Read More
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
Read More
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
Read More